Azido-PEG12-acid

CAS No. 2152679-71-3

Azido-PEG12-acid ( —— )

Catalog No. M26893 CAS No. 2152679-71-3

Azido-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 52 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Azido-PEG12-acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Azido-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    Azido-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    flap endonuclease 1 (FEN1)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2152679-71-3
  • Formula Weight
    643.7
  • Molecular Formula
    C27H53N3O14
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Application of small-molecular inhibitor SC13 targeting to FEN1 and derivative of small-molecular inhibitor SC13 in preparing tumor treatment medicine. CN106692155A.
molnova catalog
related products
  • Mosedipimod

    Mosedipimod (EC-18, 1-palmitoyl-2-linoleoyl-3-acetylglycerol) is a synthetic monoacetyldiaglyceride that stimulates T cell production of IL-2, IL-4, IL-12, IFN-γ, and GM-CSF in vitro.

  • 6-Chloro-1-tetralone

    6-Chloro-1-tetralone is an important intermediate for the synthesis of pharmaceutical compounds.

  • Bilobetin

    Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARα in rats fed a high-fat diet.